SCN1A and epilepsy: Carers of individuals with SCN1A positive DS reported epilepsy severity (as per ELDQOL) to be less severe at follow-up (1.86, SD 0.93) compared to their baseline assessment (1.63, SD 0.76, t(64) = 2.07, P = 0.042).